One approach to improving the quality and efficiency
of the acute treatment of hip fractures has been the use of
clinical pathways that aim to standardise and streamline
treatment whilst improving quality and cost effectiveness
(Antioch et al 2001; Wigfield and Boon 1996; Grudich
1991). The success of clinical pathways in elective joint
arthroplasty has been documented by Dowsey et al (1999)
and in hip fracture by Choong et al 2000, Tallis and Balla
1995; and, Ogilvie-Harris et al 1993. A number of studies
report health related quality of life (HRQoL) in elective
arthroplasty or following hip fracture (Hozak et al 1997;
Leiberman et al 1997; March et al 1999). However, there
is no evidence to date of the effects of the use of clinical
pathways for hip fractures on HRQoL or patient
satisfaction. It is not possible therefore, to state whether
pathways have a positive, negative or neutral influence on
HRQoL or patient satisfaction.